RxDoctor Payments Data

Robert Graper

Plastic and Reconstructive Surgery · Charlotte, NCNPI 1043346570

Payments from drug & device makers

What this record shows

AbbVie accounts for 84.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $5,667 and has fallen 81.4% since, to $1,052 in 2025.

$13,321in general payments, 2019–2025

Across 181 payments — averaging $73.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$11K
  • Mentor Worldwide LLC$532
  • Musculoskeletal Transplant Foundation Inc.$486
  • Motiva USA, LLC$176
  • Tepha Inc$111
  • Davol Inc.$110
  • plus $617 from 10 others

What the payments were for

  • Speaking & faculty fees$7,94760%
  • Food & beverage$5,37540%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,321 in reported general payments places this provider in the 75th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
Scopolamine16$212
ValacyclovirValacyclovir Hcl13$161
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$127
Ondansetron OdtOndansetron24$90

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →